---

Fiona Greer

Global Director, BioPharma Services Development, SGS

“I wish I’d known that the career path from A to B is not always direct – it has diversions, dead-ends, circular routes and unmapped areas! This is all part of a learning process and good experience for dealing with change, both planned and unexpected. For the future, I’d really like to see an increase in the efficiency of the R&D model of research-based pharma and biopharma – not just cost reduction, but increased innovation too.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018